scispace - formally typeset
I

Isabel Matas

Publications -  8
Citations -  17

Isabel Matas is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has co-authored 1 publications.

Papers
More filters
Journal ArticleDOI

Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause

TL;DR: In this paper , a randomized clinical trial with 84 participants in two parallel study groups, both groups received a first-line therapy based on non-hormonal moisturizers and vaginal vibrator stimulation, and participants were randomized to receive 5 weekly sessions of fractional carbon dioxide laser therapy or sham laser therapy.
Journal ArticleDOI

Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study

TL;DR: Signs and physical examination regarding sexuality and vaginal health improved significantly, while serum estradiol remained at low levels, and prasterone seems a safe and effective option to treat GSM in BCS receiving AIs.
Journal ArticleDOI

Sexual health in breast cancer survivors with genitourinary syndrome of menopause: it is only a dyspareunia issue?

TL;DR: In this paper , a preliminary study was conducted to assess sexual health in breast cancer survivors (BCS) receiving aromatase inhibitors with genitourinary syndrome of menopause (GSM) with two parallel arms (fractional CO2 laser vs. Sham laser).
Journal ArticleDOI

Sexual assessment in breast cancer survivors receiving aromatase inhibitors: Are they interested on sexology consultation?

TL;DR: In this article , aromatase inhibitors (AI) are a well-known cause of severe genitourinary syndrome of menopause (GSM) and dyspareunia.
Journal ArticleDOI

Postnatal genetic and neurodevelopmental assessment in non-placental severely small-for-gestational-age infants born at term.

TL;DR: In this paper , the frequency of genetic syndromes and childhood neurodevelopmental impairment in non-malformed term infants with severely low birthweight and no evidence of placental insufficiency was assessed.